BRIEF-Syros announces preclinical data on SY-1425
* Syros presents data at EHA supporting potential of SY-1425, its first-in-class selective RARα agonist, in genomically defined AML and MDS patients
May 18 Noble Energy Inc
* Noble Energy Inc - sells Marcellus Midstream to Quantum Energy Partners for $765 million
* Noble Energy Inc - limited partnership units represent a 33.5 percent ownership interest in Cone Midstream Partners LP
* Noble Energy- to divest holding co which owns a 50% interest in Cone gathering & 21.7 million common & subordinated limited partnership units to portfolio company of Quantum Energy Partners Source text for Eikon: Further company coverage:
June 23 A handful of drugmakers are taking their first steps toward developing marijuana-based painkillers, alternatives to opioids that have led to widespread abuse and caused the U.S. health regulator to ask for a withdrawal of a popular drug this month.